BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1702360)

  • 1. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.
    Bussemakers MJ; van de Ven WJ; Debruyne FM; Schalken JA
    Cancer Res; 1991 Jan; 51(2):606-11. PubMed ID: 1702360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Conformations and Binding Location of HMGA2·DNA Complexes Using Ion Mobility Spectrometry and 193 nm Ultraviolet Photodissociation Mass Spectrometry.
    Sipe SN; Jeanne Dit Fouque K; Garabedian A; Leng F; Fernandez-Lima F; Brodbelt JS
    J Am Soc Mass Spectrom; 2022 Jul; 33(7):1092-1102. PubMed ID: 35687872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-mobility group A1 proteins may be involved in estrogen receptor status of breast cancer.
    Harada Y; Ohe K
    Transl Cancer Res; 2020 Jun; 9(6):3784-3786. PubMed ID: 35117745
    [No Abstract]   [Full Text] [Related]  

  • 4. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.
    Zhang J; Shao S; Han D; Xu Y; Jiao D; Wu J; Yang F; Ge Y; Shi S; Li Y; Wen W; Qin W
    Int J Oncol; 2018 Aug; 53(2):659-671. PubMed ID: 29845254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of HMG-Y proteins in proliferating tissues.
    Singh D; Rajeswari MR
    Indian J Clin Biochem; 2001 Jan; 16(1):72-6. PubMed ID: 23105295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis.
    Jafarnejad SM; Ardekani GS; Ghaffari M; Li G
    Cell Mol Life Sci; 2013 Aug; 70(15):2677-96. PubMed ID: 23080209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway.
    Gwak GY; Moon TG; Lee DH; Yoo BC
    World J Gastroenterol; 2012 Feb; 18(7):679-84. PubMed ID: 22363140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Whang E
    Surgeon; 2009 Oct; 7(5):297-306. PubMed ID: 19848064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis.
    Mellone M; Rinaldi C; Massimi I; Petroni M; Veschi V; Talora C; Truffa S; Stabile H; Frati L; Screpanti I; Gulino A; Giannini G
    Neoplasia; 2008 Aug; 10(8):773-81. PubMed ID: 18670638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1: endogenous danger signaling.
    Klune JR; Dhupar R; Cardinal J; Billiar TR; Tsung A
    Mol Med; 2008; 14(7-8):476-84. PubMed ID: 18431461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.
    Dhar A; Young MR; Colburn NH
    Mol Cell Biochem; 2002; 234-235(1-2):185-93. PubMed ID: 12162432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis.
    Liu F; Chau KY; Arlotta P; Ono SJ
    Immunol Res; 2001; 24(1):13-29. PubMed ID: 11485207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.
    Reeves R; Edberg DD; Li Y
    Mol Cell Biol; 2001 Jan; 21(2):575-94. PubMed ID: 11134344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-I/Y, a new c-Myc target gene and potential oncogene.
    Wood LJ; Mukherjee M; Dolde CE; Xu Y; Maher JF; Bunton TE; Williams JB; Resar LM
    Mol Cell Biol; 2000 Aug; 20(15):5490-502. PubMed ID: 10891489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of the high mobility group I(Y) mRNA in thyroid cancers: useful tool of differential diagnosis of thyroid nodules.
    Kim SJ; Ryu JW; Choi DS
    Korean J Intern Med; 2000 Jan; 15(1):71-5. PubMed ID: 10714095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.
    Vallone D; Battista S; Pierantoni GM; Fedele M; Casalino L; Santoro M; Viglietto G; Fusco A; Verde P
    EMBO J; 1997 Sep; 16(17):5310-21. PubMed ID: 9311991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.
    Tallini G; Dal Cin P; Rhoden KJ; Chiapetta G; Manfioletti G; Giancotti V; Fusco A; Van den Berghe H; Sciot R
    Am J Pathol; 1997 Jul; 151(1):37-43. PubMed ID: 9212729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility-group proteins and cancer--an emerging link.
    Wunderlich V; Böttger M
    J Cancer Res Clin Oncol; 1997; 123(3):133-40. PubMed ID: 9119878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma.
    Xiao S; Lux ML; Reeves R; Hudson TJ; Fletcher JA
    Am J Pathol; 1997 Mar; 150(3):901-10. PubMed ID: 9060828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.
    Tamimi Y; van der Poel HG; Karthaus HF; Debruyne FM; Schalken JA
    Br J Cancer; 1996 Aug; 74(4):573-8. PubMed ID: 8761372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.